Veracyte Stock Technical Analysis
| VCYT Stock | USD 37.20 0.96 2.52% |
As of the 3rd of February, Veracyte has the Coefficient Of Variation of 2287.97, risk adjusted performance of 0.0404, and Semi Deviation of 2.66. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Veracyte, as well as the relationship between them.
Veracyte Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Veracyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VeracyteVeracyte's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Veracyte Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 47.67 | Strong Buy | 11 | Odds |
Most Veracyte analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Veracyte stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Veracyte, talking to its executives and customers, or listening to Veracyte conference calls.
Is there potential for Biotechnology market expansion? Will Veracyte introduce new products? Factors like these will boost the valuation of Veracyte. If investors know Veracyte will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Veracyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.263 | Earnings Share 0.38 | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets |
The market value of Veracyte is measured differently than its book value, which is the value of Veracyte that is recorded on the company's balance sheet. Investors also form their own opinion of Veracyte's value that differs from its market value or its book value, called intrinsic value, which is Veracyte's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Veracyte's market value can be influenced by many factors that don't directly affect Veracyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Veracyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Veracyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Veracyte's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Veracyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Veracyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Veracyte.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Veracyte on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Veracyte or generate 0.0% return on investment in Veracyte over 90 days. Veracyte is related to or competes with Kiniksa Pharmaceuticals, Zai Lab, Legend Biotech, Scholar Rock, Disc Medicine, Tarsus Pharmaceuticals, and Ideaya Biosciences. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with i... More
Veracyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Veracyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Veracyte upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.77 | |||
| Information Ratio | 0.0311 | |||
| Maximum Drawdown | 36.91 | |||
| Value At Risk | (4.02) | |||
| Potential Upside | 5.74 |
Veracyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Veracyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Veracyte's standard deviation. In reality, there are many statistical measures that can use Veracyte historical prices to predict the future Veracyte's volatility.| Risk Adjusted Performance | 0.0404 | |||
| Jensen Alpha | 0.102 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0497 | |||
| Treynor Ratio | 0.1032 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Veracyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Veracyte February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0404 | |||
| Market Risk Adjusted Performance | 0.1132 | |||
| Mean Deviation | 2.48 | |||
| Semi Deviation | 2.66 | |||
| Downside Deviation | 2.77 | |||
| Coefficient Of Variation | 2287.97 | |||
| Standard Deviation | 4.42 | |||
| Variance | 19.55 | |||
| Information Ratio | 0.0311 | |||
| Jensen Alpha | 0.102 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0497 | |||
| Treynor Ratio | 0.1032 | |||
| Maximum Drawdown | 36.91 | |||
| Value At Risk | (4.02) | |||
| Potential Upside | 5.74 | |||
| Downside Variance | 7.66 | |||
| Semi Variance | 7.07 | |||
| Expected Short fall | (3.22) | |||
| Skewness | 3.59 | |||
| Kurtosis | 22.12 |
Veracyte Backtested Returns
Veracyte owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.092, which indicates the firm had a -0.092 % return per unit of risk over the last 3 months. Veracyte exposes twenty-seven different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Veracyte's Semi Deviation of 2.66, coefficient of variation of 2287.97, and Risk Adjusted Performance of 0.0404 to confirm the risk estimate we provide. The entity has a beta of 1.78, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Veracyte will likely underperform. At this point, Veracyte has a negative expected return of -0.27%. Please make sure to validate Veracyte's sortino ratio, semi variance, as well as the relationship between the Semi Variance and day typical price , to decide if Veracyte performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Veracyte has very weak reverse predictability. Overlapping area represents the amount of predictability between Veracyte time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Veracyte price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Veracyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 4.28 |
Veracyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Veracyte Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Veracyte across different markets.
About Veracyte Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Veracyte on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Veracyte based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Veracyte price pattern first instead of the macroeconomic environment surrounding Veracyte. By analyzing Veracyte's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Veracyte's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Veracyte specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 40.82 | 38.1 | 34.29 | 34.7 | PTB Ratio | 1.91 | 2.58 | 2.96 | 2.81 |
Veracyte February 3, 2026 Technical Indicators
Most technical analysis of Veracyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Veracyte from various momentum indicators to cycle indicators. When you analyze Veracyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0404 | |||
| Market Risk Adjusted Performance | 0.1132 | |||
| Mean Deviation | 2.48 | |||
| Semi Deviation | 2.66 | |||
| Downside Deviation | 2.77 | |||
| Coefficient Of Variation | 2287.97 | |||
| Standard Deviation | 4.42 | |||
| Variance | 19.55 | |||
| Information Ratio | 0.0311 | |||
| Jensen Alpha | 0.102 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0497 | |||
| Treynor Ratio | 0.1032 | |||
| Maximum Drawdown | 36.91 | |||
| Value At Risk | (4.02) | |||
| Potential Upside | 5.74 | |||
| Downside Variance | 7.66 | |||
| Semi Variance | 7.07 | |||
| Expected Short fall | (3.22) | |||
| Skewness | 3.59 | |||
| Kurtosis | 22.12 |
Veracyte February 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Veracyte stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 37.20 | ||
| Day Typical Price | 37.20 | ||
| Price Action Indicator | (0.48) |
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.